Insider Selling: Inotiv, Inc. (NASDAQ:NOTV) CFO Sells $17,523.70 in Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $4.01, for a total transaction of $17,523.70. Following the transaction, the chief financial officer now owns 108,368 shares in the company, valued at $434,555.68. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The shares were sold at an average price of $4.46, for a total transaction of $9,160.84.

Inotiv Stock Performance

Shares of NASDAQ:NOTV opened at $4.06 on Friday. The company has a market capitalization of $136.90 million, a price-to-earnings ratio of -0.88 and a beta of 3.58. Inotiv, Inc. has a 12 month low of $1.23 and a 12 month high of $11.42. The firm’s 50-day moving average is $4.33 and its 200 day moving average is $2.96. The company has a current ratio of 1.57, a quick ratio of 1.28 and a debt-to-equity ratio of 2.31.

Inotiv (NASDAQ:NOTV) last released its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. Research analysts predict that Inotiv, Inc. will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Inotiv

Large investors have recently added to or reduced their stakes in the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new stake in Inotiv in the 4th quarter valued at about $60,000. Virtu Financial LLC purchased a new stake in shares of Inotiv in the 4th quarter worth approximately $76,000. Two Sigma Advisers LP lifted its position in shares of Inotiv by 31.6% in the 4th quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock worth $93,000 after purchasing an additional 5,400 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Inotiv by 24.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 31,626 shares of the company’s stock worth $131,000 after purchasing an additional 6,216 shares during the period. Finally, LPL Financial LLC purchased a new stake in shares of Inotiv in the 4th quarter worth approximately $136,000. 18.17% of the stock is owned by hedge funds and other institutional investors.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.